EMA Authorised: Febuxostat Krka (febuxostat) — Krka, d.d., Novo mesto

View source ↗

Summary

The EU authorities authorised Febuxostat Krka for the treatment of hyperuricemia and gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Febuxostat Krka (febuxostat)

Snippet

Status: Authorised. Therapeutic area: Hyperuricemia;Gout. MAH: Krka, d.d., Novo mesto. Decision date: 26/03/2025